| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.023 | 0.7 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.7 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.8 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |